Literature DB >> 25311509

Cardiovascular disease and kidney transplantation‑evaluation of potential transplant recipient.

Jolanta Małyszko, Hanna Bachorzewska-Gajewska, Anna Tomaszuk-Kazberuk, Joanna Matuszkiewicz-Rowińska, Magdalena Durlik, Sławomir Dobrzycki.   

Abstract

Cardiovascular evaluation of a potential kidney transplant recipient remains controversial. The burning issue is the lack of clear guidelines as well as the fact that patients with a low probability of cardiovascular disease undergo numerous unnecessary screening procedures and false‑positive results are common. In general, the standard procedure involves clinical data collection, physical examination, electrocardiography, chest‑X ray, measurement of the lipid profile and fasting glycemia, cardiac ultrasonography, followed by coronary angiography. An exercise tolerance test is not recommended because it has low sensitivity and is difficult to perform and interpret. Cardiac ultrasonography should be performed after a hemodialysis session to avoid an effect on hypervolemia. All noninvasive diagnostic imaging and isotope tests are usually of limited value and, to a large extent, are facility- and operator‑dependent. Coronary angiography should be considered in patients with positive exercise tolerance test results and a history of acute coronary syndrome, unstable coronary artery disease, and high cardiovascular risk. However, a decision regarding therapy, ie, percutaneous coronary intervention, stenting (type of stent), or coronary artery bypass grafting should be made during the meeting of a cardiac team. The guidelines also discuss cardiac contraindications to kidney transplantation. It should be stressed that a patient scheduled for a kidney transplant is sick at the time of evaluation and that his or her condition may change after several years on the waiting list. Therefore, cardiac reevaluation may be needed. Preemptive transplantation as well as short dialysis therapy before transplantation (<6 months) are associated with better patient and graft survival and thus with lower incidence of cardiovascular complications and better quality of life. The current review discusses the available guidelines on the evaluation of the potential kidney transplant recipient.

Entities:  

Mesh:

Year:  2014        PMID: 25311509

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  4 in total

Review 1.  Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?

Authors:  Elzbieta Mlodawska; Paulina Lopatowska; Jolanta Malyszko; Maciej Banach; Bożena Sobkowicz; Adrian Covic; Anna Tomaszuk-Kazberuk
Journal:  Int Urol Nephrol       Date:  2018-05-21       Impact factor: 2.370

2.  The association of diabetes with all-cause mortality in patients with end-stage renal disease compared to the general population in Poland - a comparative analysis.

Authors:  Waldemar Wierzba; Andrzej Śliwczyński; Waldemar Karnafel; Mariusz Gujski; Maciej Słodki; Aleksandra Lusawa; Jarosław Pinkas
Journal:  Arch Med Sci       Date:  2020-05-04       Impact factor: 3.318

3.  Evaluation of Atrial Electromechanical Delay to Predict Atrial Fibrillation in Hemodialysis Patients.

Authors:  Hakan Gunes; Abdullah Sokmen; Hakki Kaya; Ozkan Gungor; Murat Kerkutluoglu; Fatma Betul Guzel; Gulizar Sokmen
Journal:  Medicina (Kaunas)       Date:  2018-08-25       Impact factor: 2.430

4.  Comorbidities on kidney transplantation waiting list relative to the status of the potential recipient.

Authors:  Jolanta Malyszko; Teresa Dryl-Rydzynska; Wojciech Marcinkowski; Tomasz Prystacki; Jacek S Malyszko
Journal:  Arch Med Sci       Date:  2016-06-01       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.